Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral Agent.
Subramanian R, Tang J, Zheng J, Lu B, Wang K, Yant SR, Stepan GJ, Mulato A, Yu H, Schroeder S, Shaik N, Singh R, Wolckenhauer S, Chester A, Tse WC, Chiu A, Rhee M, Cihlar T, Rowe W, Smith BJ. Subramanian R, et al. Among authors: shaik n. Mol Pharm. 2023 Dec 4;20(12):6213-6225. doi: 10.1021/acs.molpharmaceut.3c00626. Epub 2023 Nov 2. Mol Pharm. 2023. PMID: 37917742 Free PMC article.
Pharmacokinetics, Mass Balance, Safety, and Tolerability of Obeldesivir in Healthy Participants.
Anoshchenko O, Abdelghany M, Lichtman A, Duan R, Chen H, Shaik NA, Peng CC, Yue Q, Subramanian R, Hyland RH, Davies S, Castellanos K, Mak L, Shen G, Xiao D, Caro L, Winter H, Llewellyn J, Humeniuk R. Anoshchenko O, et al. Clin Pharmacol Ther. 2024 Nov;116(5):1231-1239. doi: 10.1002/cpt.3337. Epub 2024 Jun 28. Clin Pharmacol Ther. 2024. PMID: 38940465 Clinical Trial.
Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium "Long-Acting Injectables" Working Group.
Bauer A, Berben P, Chakravarthi SS, Chattorraj S, Garg A, Gourdon B, Heimbach T, Huang Y, Morrison C, Mundhra D, Palaparthy R, Saha P, Siemons M, Shaik NA, Shi Y, Shum S, Thakral NK, Urva S, Vargo R, Koganti VR, Barrett SE. Bauer A, et al. Pharm Res. 2023 Jul;40(7):1601-1631. doi: 10.1007/s11095-022-03391-y. Epub 2023 Feb 22. Pharm Res. 2023. PMID: 36811809 Review.
Nationwide survey on awareness of consanguinity and genetic diseases in Saudi Arabia: challenges and potential solutions to reduce the national healthcare burden.
Yousef NA, ElHarouni AA, Shaik NA, Banaganapalli B, Al Ghamdi AF, Galal AH, Alahmadi TS, Shuaib T, Aljeaid D, Alshaer DS, Almutadares M, Elango R. Yousef NA, et al. Among authors: shaik na. Hum Genomics. 2024 Dec 18;18(1):138. doi: 10.1186/s40246-024-00700-x. Hum Genomics. 2024. PMID: 39695766 Free PMC article.
Exploring somatic mutations in BRAF, KRAS, and NRAS as therapeutic targets in Saudi colorectal cancer patients through massive parallel sequencing and variant classification.
Aljuhani TA, Shaik NA, Alqawas RT, Bokhary RY, Al-Mutadares M, Al Mahdi HB, Al-Rayes N, El-Harouni AA, Elango R, Banaganapalli B, Awan ZA. Aljuhani TA, et al. Among authors: shaik na. Front Pharmacol. 2024 Nov 20;15:1498295. doi: 10.3389/fphar.2024.1498295. eCollection 2024. Front Pharmacol. 2024. PMID: 39635441 Free PMC article.
Assessing the dual toxicity of HfO2 nanoparticles and quinalphos on Pila virens.
Chagantipati S, Palanisamy P, Burri G, Jalleda RL, Shaik N, Nadakuditi VR, Nasani N, Reddy RC, Srikanth K, Nutalapati V. Chagantipati S, et al. Among authors: shaik n. Sci Total Environ. 2024 Dec 20;957:177582. doi: 10.1016/j.scitotenv.2024.177582. Epub 2024 Nov 27. Sci Total Environ. 2024. PMID: 39566615
Bilateral Bell's Palsy With Herpes Zoster Virus.
Palit P, Shaik NM, Daniel B, Al-Jizani AS, Achufusi N. Palit P, et al. Among authors: shaik nm. Cureus. 2024 Nov 17;16(11):e73878. doi: 10.7759/cureus.73878. eCollection 2024 Nov. Cureus. 2024. PMID: 39559438 Free PMC article.
Physical, biochemical, and biological characterization of olive-derived lipid nanovesicles for drug delivery applications.
Zhao Z, Lacombe J, Simon L, Sanchez-Ballester NM, Khanishayan A, Shaik N, Case K, Dugas PY, Repellin M, Lollo G, Soulairol I, Harris AF, Gordon M, Begu S, Zenhausern F. Zhao Z, et al. Among authors: shaik n. J Nanobiotechnology. 2024 Nov 18;22(1):720. doi: 10.1186/s12951-024-02964-w. J Nanobiotechnology. 2024. PMID: 39558361 Free PMC article.
234 results